LyphoMed VHA private label agreement
Executive Summary
$45 mil. three-year agreement commits 480-unit Voluntary Hospitals of America non-profit "chain" to small volume parenteral purchases from LyphoMed. VHA, through its recently-established VHA Supply Company, has contracted with LyphoMed for the injectable mfr. to provide VHA-Plus private label products to member hospitals. VHA has been an aggressive group buyer of hospital supplies. The LyphoMed deal is described as the first commitment by a major healthcare system to buy private label injectables.